The 8th Annual World Intellectual Property Day is April 26, 2008, and focuses on celebrating innovation and promoting respect for intellectual property. Dr. Kamil Idris, Director General of the World Intellectual Property Organization (WIPO), highlighted the intrinsic link between creativity, innovation and IP.
Let us know what you think is the best way to celebrate World IP Day. Out-Law.com is running a photography competition for pupils at two London schools as an event to mark the date. No word yet if the Public Patent Foundation (PUBPAT) will be having any festivities. You can see a whole round-up of activities here.
Think this is all much ado about nothing? Consider this:
- Economists estimate that two-thirds of the value of large businesses in the US is due to intangible or intellectual property assets.
- The World Bank estimates that, on average, 40% of company valuations are from intellectual property.
- PriceWatershouseCoopers estimated that as much as 90% of the value of the world’s top 2000 enterprises would consist of intellectual property.
And so, on World Intellectual Property Day, here’s to you o’ inventors and artists, great and small, who enrich our existence with the fruits of their innovative thoughts and creative vision. Cheer!
See more on World IP Day here. You can even download and print your own Innovation postcards.
More News and learn more about M&A’s, partnerships ect and network with more than 10,000 Pharmaceutical & Biotechnology professionals & friends at http://www.mybiopartner.com
Sorry to wax rather Off-topic, here — but I thought this worth mentioning, as I haven’t seen anyone else on the Web — or off it — mentioning this, one as news:
“. . . .While the chemical structure commonly known as desloratadine (imaged, on site — sold by Schering-Plough as Clarinex) doesn’t come off of a Schering patent until about 2020, an important new development has appeared, in federal court documents just filed April 16, 2008, in Schering’s own suit to keep several would-be generic makers from selling desloratadine, as the chemical equivalent of Clarinex RediTabs.
In the In Re Descloratadine Patent Litigation (MDL No. 1851, Case No. 3:07-CV-3930 US Dist. Ct. NJ), Orchid Chemicals, an Indian company, and one of the would-be generic competitors, was granted leave to file and just filed (April 16) an Amended Answer to Schering’s Amended Complaint. Orchid’s new and improved answer sets out a very-interesting factual counterclaim to Schering’s assertion that so-called FDA “Orange Book” status applies, at least as to Clarinex RediTabs. . . .”
Do take a look.
[…] World Intellectual Property Day 2008 – Celebrating Innovation […]